错失的机会:日本梅毒检测患者的艾滋病毒检测不足

IF 1.5 4区 医学 Q3 INFECTIOUS DISEASES
Toshibumi Taniguchi, Kazutaka Yamagishi, Misuzu Yahaba, Hiroshi Yoshikawa, Hidetoshi Igari
{"title":"错失的机会:日本梅毒检测患者的艾滋病毒检测不足","authors":"Toshibumi Taniguchi,&nbsp;Kazutaka Yamagishi,&nbsp;Misuzu Yahaba,&nbsp;Hiroshi Yoshikawa,&nbsp;Hidetoshi Igari","doi":"10.1016/j.jiac.2025.102816","DOIUrl":null,"url":null,"abstract":"<div><div>Japan faces dual challenges of rising syphilis incidence and persistent late HIV diagnoses, with approximately 30 % of new HIV cases identified at AIDS stage. This study analyzed HIV testing practices among syphilis-tested patients using National Database of Health Insurance Claims sampling data (2011–2020). Among 253,865 patients tested for syphilis, only 13,485 (5.31 %) underwent HIV testing. HIV testing rates showed a concerning age-related decline from 8.27 % in patients under 20 years to 4.67 % in those over 70 years (Cochran-Armitage trend test, p &lt; 0.0001). This age-based disparity persisted across both sexes and showed no improvement over the study period (p = 0.24). Among 22,961 patients who received antibiotic treatment for any sexually transmitted infection (STI), only 905 (3.94 %) underwent HIV testing. The inverse relationship between testing rates and age is particularly alarming given that older patients have the highest risk of late HIV diagnosis, with 56.9 % of those over 70 diagnosed at AIDS stage compared to 10.0 % of those under 20. These findings reveal critical implementation gaps in HIV testing despite international guidelines recommending routine testing for all STI patients. The persistent low testing rates across all age groups, combined with systematic age-based disparities, indicate entrenched system failures requiring urgent policy intervention. Implementing opt-out HIV testing for all STI evaluations could substantially reduce missed opportunities for early HIV detection and improve public health outcomes.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"31 10","pages":"Article 102816"},"PeriodicalIF":1.5000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Missed opportunities: HIV testing deficits among syphilis-tested patients in Japan\",\"authors\":\"Toshibumi Taniguchi,&nbsp;Kazutaka Yamagishi,&nbsp;Misuzu Yahaba,&nbsp;Hiroshi Yoshikawa,&nbsp;Hidetoshi Igari\",\"doi\":\"10.1016/j.jiac.2025.102816\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Japan faces dual challenges of rising syphilis incidence and persistent late HIV diagnoses, with approximately 30 % of new HIV cases identified at AIDS stage. This study analyzed HIV testing practices among syphilis-tested patients using National Database of Health Insurance Claims sampling data (2011–2020). Among 253,865 patients tested for syphilis, only 13,485 (5.31 %) underwent HIV testing. HIV testing rates showed a concerning age-related decline from 8.27 % in patients under 20 years to 4.67 % in those over 70 years (Cochran-Armitage trend test, p &lt; 0.0001). This age-based disparity persisted across both sexes and showed no improvement over the study period (p = 0.24). Among 22,961 patients who received antibiotic treatment for any sexually transmitted infection (STI), only 905 (3.94 %) underwent HIV testing. The inverse relationship between testing rates and age is particularly alarming given that older patients have the highest risk of late HIV diagnosis, with 56.9 % of those over 70 diagnosed at AIDS stage compared to 10.0 % of those under 20. These findings reveal critical implementation gaps in HIV testing despite international guidelines recommending routine testing for all STI patients. The persistent low testing rates across all age groups, combined with systematic age-based disparities, indicate entrenched system failures requiring urgent policy intervention. Implementing opt-out HIV testing for all STI evaluations could substantially reduce missed opportunities for early HIV detection and improve public health outcomes.</div></div>\",\"PeriodicalId\":16103,\"journal\":{\"name\":\"Journal of Infection and Chemotherapy\",\"volume\":\"31 10\",\"pages\":\"Article 102816\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection and Chemotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1341321X25002132\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X25002132","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

日本面临着梅毒发病率上升和艾滋病毒诊断持续滞后的双重挑战,大约30%的新艾滋病毒病例在艾滋病阶段被发现。本研究利用国家健康保险索赔数据库抽样数据(2011-2020年)分析了梅毒检测患者的艾滋病毒检测做法。在接受梅毒检测的253,865名患者中,只有13,485名(5.31%)接受了艾滋病毒检测。HIV检测率与年龄相关,从20岁以下患者的8.27%下降到70岁以上患者的4.67% (Cochran-Armitage趋势检验,p < 0.0001)。这种基于年龄的差异在两性之间持续存在,并且在研究期间没有显示出改善(p = 0.24)。在接受任何性传播感染(STI)抗生素治疗的22,961名患者中,只有905名(3.94%)接受了艾滋病毒检测。检测率与年龄之间的反比关系尤其令人担忧,因为老年患者晚期诊断艾滋病毒的风险最高,70岁以上的患者中56.9%被诊断为艾滋病阶段,而20岁以下的患者中这一比例为10.0%。尽管国际指南建议对所有性传播感染患者进行常规检测,但这些发现揭示了艾滋病毒检测实施方面的重大差距。所有年龄组的检测率持续较低,加上系统性的年龄差异,表明根深蒂固的系统故障需要紧急政策干预。在所有性传播感染评估中实施选择性退出艾滋病毒检测,可大大减少错过早期发现艾滋病毒的机会,并改善公共卫生成果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Missed opportunities: HIV testing deficits among syphilis-tested patients in Japan
Japan faces dual challenges of rising syphilis incidence and persistent late HIV diagnoses, with approximately 30 % of new HIV cases identified at AIDS stage. This study analyzed HIV testing practices among syphilis-tested patients using National Database of Health Insurance Claims sampling data (2011–2020). Among 253,865 patients tested for syphilis, only 13,485 (5.31 %) underwent HIV testing. HIV testing rates showed a concerning age-related decline from 8.27 % in patients under 20 years to 4.67 % in those over 70 years (Cochran-Armitage trend test, p < 0.0001). This age-based disparity persisted across both sexes and showed no improvement over the study period (p = 0.24). Among 22,961 patients who received antibiotic treatment for any sexually transmitted infection (STI), only 905 (3.94 %) underwent HIV testing. The inverse relationship between testing rates and age is particularly alarming given that older patients have the highest risk of late HIV diagnosis, with 56.9 % of those over 70 diagnosed at AIDS stage compared to 10.0 % of those under 20. These findings reveal critical implementation gaps in HIV testing despite international guidelines recommending routine testing for all STI patients. The persistent low testing rates across all age groups, combined with systematic age-based disparities, indicate entrenched system failures requiring urgent policy intervention. Implementing opt-out HIV testing for all STI evaluations could substantially reduce missed opportunities for early HIV detection and improve public health outcomes.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy INFECTIOUS DISEASES-PHARMACOLOGY & PHARMACY
CiteScore
4.10
自引率
4.50%
发文量
303
审稿时长
47 days
期刊介绍: The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信